Zipnosis Appoints Dr. Lisa Ide as New Chief Medical Officer

Zipnosis, a virtual care technology leader, announced Tuesday that Dr. Lisa Ide will be the company’s new chief medical officer.

Dr. Ide succeeds Dr. Rebecca Hafner-Fogarty, who will continue to serve as senior vice president of policy and strategy, MHW confirmed.

Dr. Ide joined Zipnosis in 2016, as the company’s medical director – a role in which “she touched every part of the business.”

An active member on the Clinical Quality Advisory Council, she works closely with the customer success team to help bring health system voices to the clinical product development conversation and has served as a clinical liaison for the sales team. As chief medical officer, she will be responsible for identifying clinical opportunities, understanding the industry’s pain points and ensuring the Zipnosis platform is meeting customers’ clinical needs.

“Over the past year, Lisa’s contributions to our clinical work, customer relationships and team have been uniformly exceptional,” said Jon Pearce, CEO, Zipnosis. “In 2017, Zipnosis had a great year, and there is significant opportunity for us to continue that momentum with further development of customer-centric solutions that can broaden the adoption of virtual care. With both Dr. Ide and Dr. Hafner-Fogarty’s expertise and industry background, we look forward to their visions impacting the platform’s direction.”

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author